Medicines Marketed by Emil Pharmaceuticals Industries Pvt Ltd

About Emil Pharmaceutical Industries Private Limited

Emil Pharmaceutical Industries Private Limited is a renowned pharmaceutical company based in Mumbai, India. It has been operating in the industry since its establishment in 1986. The company specialises in manufacturing a wide range of allopathic formulations, nutraceuticals, and over-the-counter (OTC) products. With a strong commitment to quality and compliance, Emil Pharmaceutical Industries Private Limited has gained global recognition, with its products registered and accredited by various international regulatory bodies, including WHO-GMP, NAFDAC Nigeria, FDA Philippines, and FDA Ghana. This extensive global presence spans across South America, Africa, and Asia, showcasing the company's dedication to providing high-quality pharmaceutical products to a diverse audience worldwide.

Emil Pharmaceutical Industries Private Limited Products

Emil Pharmaceutical Industries Private Limited offers a comprehensive portfolio of pharmaceutical products in various dosage forms, such as tablets, capsules, dry powders, creams, oral liquids, ointments, and gels. These products cater to multiple therapeutic categories, including cardiovasculars, antibacterials, antifungals, antiprotozoals, antihelminitics, antiretrovirals, gastro-intestinals, genitourinary medications, musculo-skeletal remedies, anti-obesity medications, neutraceuticals, and anticancer tablets. Some of the company's most popular products include Amlodipine, Lisinopril, Azithromycin, Ciprofloxacin, Amitriptyline, Fluoxetine, Famotidine, and Lansoprazole. Emil Pharmaceutical Industries Private Limited collaborates with several multinational companies, such as Pfizer, Merck, and GlaxoSmithKline, further enhancing its credibility and capabilities in contract manufacturing and product development. The company's state-of-the-art manufacturing facilities adhere to global safety and efficacy standards, including Good Manufacturing Practices (GMP), ensuring the production of high-quality and reliable treatments that meet international regulatory standards.